Elevated SMAD1 expression was detected in GC tissue and cells; studies demonstrated that SMAD1 can interact with Yes1-associated transcriptional regulator (YAP1) to enhance the cisplatin resistance of GC cells [35]. Here, SMAD1 is linked to gastric cancer.